期刊文献+

糖耐量正常的腹型肥胖男青年丙二醛、总体抗氧化能力、25-羟维生素D_3水平及其与胰岛素抵抗的关系研究 被引量:6

Levels of MDA,T-Aoc,25-( OH) D_3 Related to IR: A Study of Abdominal-Obesity Young Men with Normal Glucose Tolerance
下载PDF
导出
摘要 目的:探讨糖耐量正常的腹型肥胖男青年丙二醛( mDA)、总体抗氧化能力( T-Aoc)、25-羟维生素D3〔25-( OH) D3〕水平及其与胰岛素抵抗( IR)的关系。方法采用随机数字表法选取2012年11月-2013年2月在秦皇岛市第一医院体检中心进行体检的25~45岁糖耐量正常男青年81例,并以腰围≥90 cm作为腹型肥胖诊断标准,将其分为腹型肥胖者39例(病例组)和腰围正常者42例(对照组)。测量血压〔收缩压( SBP)和舒张压(DBP)〕、腰围、体质指数(BmI)、空腹血糖(FPG)、空腹胰岛素(FINS)、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、mDA、T-Aoc、25-(OH)D3、餐后2 h血糖(2 hPG)、餐后2 h胰岛素(2 hINS)。采用Pearson线性相关分析和多元线性回归分析mDA、T-Aoc、25-(OH)D3水平与胰岛素抵抗指数( HOmA-IR)的关系。结果两组的TC、LDL-C、FPG、2 hPG水平比较,差异均无统计学意义(P﹥0.05)。病例组腰围、BmI、SBP、DBP、TG、FINS、2 hINS、mDA水平及HOmA-IR均高于对照组,而HDL-C、T-Aoc、25-(OH)D3水平均低于对照组(P﹤0.05)。Pearson线性相关分析显示,T-Aoc与BmI、腰围、DBP、HOmA-IR呈负相关(r=-0.451、-0.472、-0.430、-0.462,P﹤0.05),与HDL-C、25-(OH)D3呈正相关(r=0.474、0.472,P﹤0.05);mDA与BmI、腰围、2 hPG 、HOmA-IR呈正相关(r=0.402、0.495、0.504、0.566, P﹤0.05),与25-(OH)D3呈负相关(r=-0.459,P﹤0.05)。多元线性回归分析显示,25-(OH)D3、mDA与HOmA-IR相关性最强,HOmA-IR与25-(OH)D3呈负相关,与 mDA 呈正相关(标准化偏回归系数=-0.383、0.356,P﹤0.05)。结论糖耐量正常的腹型肥胖男青年易发生mDA水平升高、T-Aoc及维生素D水平下降,且mDA及维生素D是IR的主要影响因素,为今后的临床研究提供了参考价值。 Objective To investigate the levels of malondialdehyde (MDA), total antioxidant capacity (T- Aoc), 25 -hydroxy vitamin D3 [25 - (OH) D3 ] and their relationship to insulin resistance (IR) in obese young men with normal glucose tolerance (NGT). Methods Eighty - one young men with NGT having physical examinations in the First Hospital of Qinhuangdao from November 2012 to February 2013 were divided, taking WC ≥90 cm as diagnostic criteria of abdominal - obesity, into groups obesity (n=39), control (n =42). SBP, DBP, WC, BMI, FPG, FINS, TG, TC, HDL-C, LDL- C, MDA, T - Aoc, 25 - (OH) D3, 2 hPG, 2 hINS were determined. Pearson linear correlation analysis and multiple linear regression analysis were used to analyze the relationship of MDA, T-Aoc, 25- (OH) D3 to insulin resistance index ( HOMA - IR). Results There was no significant difference in levels of TC, LDL - C, FPG, 2 hPG between 2 groups (P 〉 0.05). WC, BMI, SBP, DBP, TG, FINS, 2 hlNS, MDA, HOMA - IR were higher in obesity group than in control group , HDL - C, T - Aoc, 25 - (OH) D3 lower (P 〈 0. 05). By Pearson linear correlation analysis, T - Aoc was negatively corre- lated with BMI, WC, DBP, HOMA - IR (r = - 0. 451, - 0. 472, - 0. 430, - 0. 462, P 〈 0.05), positively with HDL -C, 25- (OH) D3 (r=0.474, 0.472, P 〈0.05); MDA was positively correlated with BMI, WC, 2 hPG, HOMA-IR (r=0.402, 0.495, 0.504, 0.566, P〈0.05), negatively with 25- (OH) D3 (r=-0.459, P〈0.05). By multiple linear regression analysis, the correlation between 25 - (OH) D3, MDA and HOMA -IR was the strongest, HOMA- IR was negatively correlated with 25 - (OH) D3, positively with MDA ( standardized partial regression coefficient = - 0. 383, 0. 356, P 〈 0.05 ). Conclusion MDA increases, T- Aoe and vitamin D decrease in abdominal- obesity young men with NGT, MDA and vitamin D are the main influencing factors of IR, and provides a reference value for future clinical research.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第20期2341-2344,共4页 Chinese General Practice
关键词 腹型肥胖 丙二醛 抗氧化能力 维生素D 氧化应激 胰岛素抵抗 Abdominal obesity Malondialdehyde Antioxidant Vitamin D Oxidative stress Insulin resistance
  • 相关文献

参考文献14

  • 1Kaneto H, Katakami N, Kawamori D, et al. Involvement of oxidative stress in the pathogenesis of diabetes [ J ]. Antioxid Redox Signal, 2007, 9 (3): 355-366.
  • 2Chaeko SA, Song Y, Manson JE, et al. Serum 25 - hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal wemen [J]. Am J Clin Nutr, 2011, 94 (1): 209-217.
  • 3American Diabetes Association. Diagnosis and classification of diabetes mellitus [J]. Diabetes Care, 2008, 31 (Supplement 1 ): S55 - S60.
  • 4Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome a new worldwide definition [J]. Lancet 2005, 366 (9491) : 1059 - 1062.
  • 5El - Osta A, Brasacchio D, Yao D, et al. Transient high glucose cau- ses persistent epigenetic changes and altered gene expression during sub -sequent normoglyeemia [J]. J Exp Med, 2008, 205 (10): 2409 - 2417.
  • 6Moy FM, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia [J]. BMC Public Heahh, 2011, 11 (9) : 735 -741.
  • 7Seo JA, Eun CR, Cho I-I, et al. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults [J]. PLoS One, 2013, 8 (10): e75197.
  • 8Jorde R, Sneve M, Torjesen P, et al. No improvement in cardiovascu- lar risk factors in overweight and obese subjects after supplementation with vitamin D3 for l year [J]. J Inter Med, 2010, 267 (5): 462- 472.
  • 9Luquet S, Gaudel C, Hoist D, et al. Roles of PPAR delta in lipid ab- sorption and metabolism: a new target for the treatmenf of type 2 diabe- tes [J]. Biochim Biophys Acts, 2005, 1740 (2): 313-317.
  • 10Asemi Z, Samimi M, Tabassi Z, et al. Vitamin D supplementation affects serum high- sensitivity C -reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women [ J ]. J Nutr, 2013, 143 (9): 1432-1438.

二级参考文献9

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Gaman SA, Balakhonova TV, Sinitsyn VE, et al. Structural and func- tional changes of coronary and carotid arteries in patients with ischemic heart disease [J] . Ter Arkh, 2005, 77 (4) : 15 -21.
  • 3Watts NB, Lewiecki EM, Miller PD, et al. National osteoporosis founda- tion 2008 clinician's guide to prevention and treatment of osteoporosis and the world health organization fracture risk assessment tool (FRAX) : what they mean to the bone densitometrist and bone technologist [ J ] . J Clin Densitom, 2008, 11 (4) : 473 -477.
  • 4Viskari H, Kondrashova A, Koskela P, et al. Circulating vitamin D con- centrations in two neighboring populations with markedly different inci- dence of type 1 diabetesl [J] . Diabetes Care, 2006, 29 (6) : 1458 - 1459.
  • 5Botella - Carretero JI, Alvarez - Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity [J] . Clin Nutr, 2007, 26 (5): 573-580.
  • 6Keman WN, Inzucchi SE, Viscili CM, et al. Insulinresistance and risk for stroke [J] . Neurology, 2002, 59 (6): 809-815.
  • 7Abraham WT. Preventing cardiovascular events in patients with diabetes mellitus [J] . Am J Med, 2004, 116 (Supp15A) : 39 -46.
  • 8郭丽芳,李彩萍.血维生素D与2型糖尿病及其大血管病变关系的研究进展[J].疑难病杂志,2011,10(11):879-881. 被引量:4
  • 9黄金,周智广.维生素D与代谢综合征关系的研究进展[J].医学综述,2011,17(23):3521-3523. 被引量:12

共引文献14

同被引文献38

  • 1邹大进,吴鸿.肥胖症及脂代谢紊乱的诊断[J].国际内分泌代谢杂志,2006,26(1):1-4. 被引量:52
  • 2Vinik AI, Erbas T, et al. Diabetic autonomic neuropathy [ M ]. Handb Clin Neurol, 2013 : 279 -294.
  • 3Tesfaye S, Boulton A J, Dyck PJ, et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments [J]. Diabetes Care, 2010, 33 (10): 2285- 2293.
  • 4Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic Acid [J]. Front Pharmacol, 2011, 2(11): 69.
  • 5Marilia Brito Comes, Carlos Antonio Negrato. Alpha - lipoic acid as a pleiotropic compound with potential therapeutic use in diabe- tes and other chronic diseases [ J ]. Diabetology & Metabolic Syn- drome, 2014, 6(1): 80.
  • 6McIlduff CE, Rutkove SB. Critical appraisal of the use of alpha li- poic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy[J]. Ther Clin Risk Manag, 2011,7(9) : 377 -385.
  • 7May O, Arildsen H. Simple function tests for autonomic neuropa- thy have a higher predictive value on all - cause mortality in dia- betes compared to 24 - h heart [ J ]. Diabetes Complications, 2012, 26:246 -250.
  • 8Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study [J]. Lancet, 2008, 371 (9626) : 1783-1789.
  • 9Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients [J]. Diabetes Care, 2006,29 ( 3 ) : 722- 724.
  • 10Bonakdaran S, Varasteh AR.Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients [ J]. Sandi Med J, 2009,30 ( 4 ) : 509- 514.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部